Current Choices and Management of Treatment in Persons with Severe Hemophilia A without Inhibitors: A Mini-Delphi Consensus.
Antonio CoppolaMassimo FranchiniGiovanni Luigi PappagalloAlessandra BorchielliniRaimondo De CristofaroAngelo Claudio MolinariRita Carlotta SantoroCristina SantoroAnnarita TagliaferriPublished in: Journal of clinical medicine (2022)
The increased treatment options extend the opportunities of personalized prophylaxis, the mainstay of modern management of hemophilia. Close, long-term clinical and laboratory follow-up of patients using newer therapeutic approaches by specialized hemophilia treatment centers is needed.